{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:53Z","timestamp":1793995613710,"version":"4.8.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177004"],"award-info":[{"award-number":["22177004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92153301"],"award-info":[{"award-number":["92153301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Targeted degradation of proteins has emerged as a powerful method for modulating protein homeostasis. Identification of suitable degraders is essential for achieving effective protein degradation. Here, we present a non-covalent degrader construction strategy, based on a modular supramolecular co-assembly system consisting of two self-assembling peptide ligands that bind cell membrane receptors and the protein of interest simultaneously, resulting in targeted protein degradation. The developed lysosome-targeting co-assemblies (LYTACAs) can induce lysosomal degradation of extracellular protein IL-17A and membrane protein PD-L1 in several scavenger receptor A-expressing cell lines. The IL-17A-degrading co-assembly has been applied in an imiquimod-induced psoriasis mouse model, where it decreases IL-17A levels in the skin lesion and alleviates psoriasis-like inflammation. Extending to asialoglycoprotein receptor-related protein degradation, LYTACAs have demonstrated the versatility and potential in streamlining degraders for extracellular and membrane proteins.<\/jats:p>","DOI":"10.1038\/s41467-024-46130-0","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:03:02Z","timestamp":1708686182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-4344","authenticated-orcid":false,"given":"Suwei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"46130_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao, L., Zhao, J., Zhong, K., Tong, A. & Jia, D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct. Target Ther. 7, 113 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"46130_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","volume":"20","author":"D Chirnomas","year":"2023","unstructured":"Chirnomas, D., Hornberger, K. R. & Crews, C. M. Protein degraders enter the clinic - a new approach to cancer therapy. Nat. Rev. Clin. Oncol. 20, 265\u2013278 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"46130_CR3","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","volume":"98","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 98, 8554\u20138559 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"46130_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","volume":"76","author":"D Takahashi","year":"2019","unstructured":"Takahashi, D. et al. AUTACs: cargo-specific degraders using selective autophagy. Mol. Cell 76, 797\u2013810 (2019).","journal-title":"Mol. Cell"},{"key":"46130_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik, S. M. et al. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 584, 291\u2013297 (2020).","journal-title":"Nature"},{"key":"46130_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41589-021-00851-1","volume":"17","author":"DF Caianiello","year":"2021","unstructured":"Caianiello, D. F. et al. Bifunctional small molecules that mediate the degradation of extracellular proteins. Nat. Chem. Biol. 17, 947\u2013953 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"46130_CR7","doi-asserted-by":"publisher","first-page":"15448","DOI":"10.1002\/anie.202004310","volume":"59","author":"LM Luh","year":"2020","unstructured":"Luh, L. M. et al. Prey for the proteasome: targeted protein degradation - a medicinal chemist\u2019s perspective. Angew. Chem. Int. Ed. 59, 15448\u201315466 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"46130_CR8","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1021\/acschembio.3c00229","volume":"18","author":"TC Donahue","year":"2023","unstructured":"Donahue, T. C. et al. Synthetic site-specific antibody-ligand conjugates promote asialoglycoprotein peceptor-mediated degradation of extracellular human PCSK9. ACS Chem. Biol. 18, 1611\u20131623 (2023).","journal-title":"ACS Chem. Biol."},{"key":"46130_CR9","doi-asserted-by":"publisher","first-page":"21831","DOI":"10.1021\/jacs.2c08367","volume":"144","author":"J Zheng","year":"2022","unstructured":"Zheng, J. et al. Bifunctional compounds as molecular degraders for integrin-facilitated targeted protein degradation. J. Am. Chem. Soc. 144, 21831\u201321836 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"46130_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-021-00770-1","volume":"17","author":"G Ahn","year":"2021","unstructured":"Ahn, G. et al. LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation. Nat. Chem. Biol. 17, 937\u2013946 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"46130_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/acscentsci.1c00146","volume":"7","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y., Teng, P., Montgomery, N. T., Li, X. & Tang, W. Development of triantennary N-acetylgalactosamine conjugates as degraders for extracellular proteins. ACS Cent. Sci. 7, 499\u2013506 (2021).","journal-title":"ACS Cent. Sci."},{"key":"46130_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41587-022-01456-2","volume":"41","author":"K Pance","year":"2022","unstructured":"Pance, K. et al. Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins. Nat. Biotechnol. 41, 273\u2013281 (2022).","journal-title":"Nat. Biotechnol."},{"key":"46130_CR13","doi-asserted-by":"publisher","first-page":"e202300694","DOI":"10.1002\/anie.202300694","volume":"62","author":"C Zhu","year":"2023","unstructured":"Zhu, C. et al. chimeras harness scavenger receptors to degrade cell membrane proteins. Angew. Chem. Int. Ed. 62, e202300694 (2023).","journal-title":"Angew. Chem. Int. Ed."},{"key":"46130_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556\u2013567 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"46130_CR15","doi-asserted-by":"publisher","first-page":"e202203624","DOI":"10.1002\/chem.202203624","volume":"29","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Fine tuning the properties of stapled peptides by stereogenic \u03b1\u2010amino acid bridges. Chem. Eur. J. 29, e202203624 (2023).","journal-title":"Chem. Eur. J."},{"key":"46130_CR16","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","volume":"371","author":"KA Papp","year":"2008","unstructured":"Papp, K. A. et al. Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371, 1675\u20131684 (2008).","journal-title":"Lancet"},{"key":"46130_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jdermsci.2011.05.005","volume":"63","author":"TF Tsai","year":"2011","unstructured":"Tsai, T. F. et al. Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL). J. Dermatol. Sci. 63, 154\u2013163 (2011).","journal-title":"J. Dermatol. Sci."},{"key":"46130_CR18","doi-asserted-by":"publisher","first-page":"R790","DOI":"10.1016\/j.cub.2020.05.051","volume":"30","author":"A Alquraini","year":"2020","unstructured":"Alquraini, A. & El Khoury, J. Scavenger receptors. Curr. Biol. 30, R790\u2013R795 (2020).","journal-title":"Curr. Biol."},{"key":"46130_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cells4020178","volume":"4","author":"IA Zani","year":"2015","unstructured":"Zani, I. A. et al. Scavenger receptor structure and function in health and disease. Cells 4, 178\u2013201 (2015).","journal-title":"Cells"},{"key":"46130_CR20","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1021\/acs.molpharmaceut.0c00562","volume":"17","author":"DM Stevens","year":"2020","unstructured":"Stevens, D. M. et al. Application of a scavenger receptor A1-targeted polymeric prodrug platform for lymphatic drug delivery in HIV. Mol. Pharm. 17, 3794\u20133812 (2020).","journal-title":"Mol. Pharm."},{"key":"46130_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0014-5793(94)80511-3","volume":"342","author":"S Basu","year":"1994","unstructured":"Basu, S., Mukhopadhyay, B., Basu, S. K. & Mukhopadhyay, A. Enhanced intracellular delivery of doxorubicin by scavenger receptor\u2010mediated endocytosis for preferential killing of histiocytic lymphoma cells in culture. FEBS Lett. 342, 249\u2013254 (1994).","journal-title":"FEBS Lett."},{"key":"46130_CR22","doi-asserted-by":"publisher","first-page":"3523642","DOI":"10.1155\/2018\/3523642","volume":"2018","author":"C-H Lu","year":"2018","unstructured":"Lu, C.-H. et al. Involvement of M1 macrophage polarization in endosomal Toll-like receptors activated psoriatic inflammation. Mediators Inflamm. 2018, 3523642 (2018).","journal-title":"Mediators Inflamm."},{"key":"46130_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep26071","volume":"6","author":"S Liu","year":"2016","unstructured":"Liu, S. et al. Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide. Sci. Rep. 6, 26071 (2016).","journal-title":"Sci. Rep."},{"key":"46130_CR24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1042\/BST0350784","volume":"35","author":"S Futaki","year":"2007","unstructured":"Futaki, S., Nakase, I., Tadokoro, A., Takeuchi, T. & Jones, A. T. Arginine-rich peptides and their internalization mechanisms. Biochem. Soc. Trans. 35, 784\u2013787 (2007).","journal-title":"Biochem. Soc. Trans."},{"key":"46130_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0021-9258(18)89703-4","volume":"260","author":"BL Clarke","year":"1985","unstructured":"Clarke, B. L. & Weigel, P. H. Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. J. Biol. Chem. 260, 128\u2013133 (1985).","journal-title":"J. Biol. Chem."},{"key":"46130_CR26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1161\/01.ATV.0000220171.50282.0c","volume":"26","author":"Y Chen","year":"2006","unstructured":"Chen, Y. et al. The di-leucine motif contributes to class a scavenger receptor-mediated internalization of acetylated lipoproteins. Arterioscler. Thromb. Vasc. Biol. 26, 1317\u20131322 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"46130_CR27","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.yexcr.2007.02.011","volume":"313","author":"E Amiel","year":"2007","unstructured":"Amiel, E., Nicholson-Dykstra, S., Walters, J. J., Higgs, H. & Berwin, B. Scavenger receptor-A functions in phagocytosis of E. coli by bone marrow dendritic cells. Exp. Cell Res. 313, 1438\u20131448 (2007).","journal-title":"Exp. Cell Res."},{"key":"46130_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98633-1","volume":"11","author":"M Ahmadi","year":"2021","unstructured":"Ahmadi, M. & Chen, Z. Spotlight onto surfactant-steam-bitumen interfacial behavior via molecular dynamics simulation. Sci. Rep. 11, 19660 (2021).","journal-title":"Sci. Rep."},{"key":"46130_CR29","doi-asserted-by":"publisher","first-page":"21807","DOI":"10.1002\/anie.202103507","volume":"60","author":"L Hu","year":"2021","unstructured":"Hu, L. et al. Structure-based programming of supramolecular assemblies in living cells for Selective cancer cell inhibition. Angew. Chem. Int. Ed. 60, 21807\u201321816 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"46130_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke, W. H. & Schon, M. P. Psoriasis. Lancet 386, 983\u2013994 (2015).","journal-title":"Lancet"},{"key":"46130_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40259-014-0098-x","volume":"28","author":"S Adami","year":"2014","unstructured":"Adami, S., Cavani, A., Rossi, F. & Girolomoni, G. The role of interleukin-17A in psoriatic disease. BioDrugs 28, 487\u2013497 (2014).","journal-title":"BioDrugs"},{"key":"46130_CR32","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec, P. & Kolls, J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763\u2013776 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"46130_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","volume":"201","author":"JE Hawkes","year":"2018","unstructured":"Hawkes, J. E., Yan, B. Y., Chan, T. C. & Krueger, J. G. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J. Immunol. 201, 1605\u20131613 (2018).","journal-title":"J. Immunol."},{"key":"46130_CR34","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI27179","volume":"116","author":"A Stratis","year":"2006","unstructured":"Stratis, A. et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J. Clin. Investig. 116, 2094\u20132104 (2006).","journal-title":"J. Clin. Investig."},{"key":"46130_CR35","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1172\/JCI29441","volume":"116","author":"RA Clark","year":"2006","unstructured":"Clark, R. A. & Kupper, T. S. Misbehaving macrophages in the pathogenesis of psoriasis. J. Clin. Investig. 116, 2084\u20132087 (2006).","journal-title":"J. Clin. Investig."},{"key":"46130_CR36","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter, B. & Nestle, F. O. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur. J. Immunol. 43, 3138\u20133146 (2013).","journal-title":"Eur. J. Immunol."},{"key":"46130_CR37","first-page":"78","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J. Biomed. Res. 26, 78 (2019).","journal-title":"J. Biomed. Res."},{"key":"46130_CR38","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1158\/0008-5472.CAN-18-3208","volume":"79","author":"H Xiong","year":"2019","unstructured":"Xiong, H. et al. Anti-PD-L1 treatment results in functional remodeling of the macrophage compartment. Cancer Res. 79, 1493\u20131506 (2019).","journal-title":"Cancer Res."},{"key":"46130_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1158\/2326-6066.CIR-17-0035","volume":"6","author":"C Li","year":"2018","unstructured":"Li, C. et al. Peptide blocking of PD-1\/PD-L1 interaction for cancer immunotherapy. Cancer Immunol. Res. 6, 178\u2013188 (2018).","journal-title":"Cancer Immunol. Res."},{"key":"46130_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1194\/jlr.R400011-JLR200","volume":"46","author":"DR Greaves","year":"2005","unstructured":"Greaves, D. R. & Gordon, S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46, 11\u201320 (2005).","journal-title":"J. Lipid Res."},{"key":"46130_CR41","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/jacs.7b09024","volume":"140","author":"P Wang","year":"2018","unstructured":"Wang, P. et al. Visualization of the cellular uptake and trafficking of DNA origami nanostructures in cancer cells. J. Am. Chem. Soc. 140, 2478\u20132484 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"46130_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1021\/acsabm.2c01041","volume":"6","author":"IW Hamley","year":"2023","unstructured":"Hamley, I. W. Self-assembly, bioactivity, and nanomaterials applications of peptide conjugates with bulky aromatic terminal groups. ACS Appl. Bio Mater. 6, 384\u2013409 (2023).","journal-title":"ACS Appl. Bio Mater."},{"key":"46130_CR43","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/adma.200501522","volume":"18","author":"V Jayawarna","year":"2006","unstructured":"Jayawarna, V. et al. Nanostructured hydrogels for three-dimensional cell culture through self-assembly of fluorenylmethoxycarbonyl-dipeptides. Adv. Mater. 18, 611\u2013614 (2006).","journal-title":"Adv. Mater."},{"key":"46130_CR44","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/adma.200501765","volume":"18","author":"A Mahler","year":"2006","unstructured":"Mahler, A., Reches, M., Rechter, M., Cohen, S. & Gazit, E. Rigid, self-assembled hydrogel composed of a modified aromatic dipeptide. Adv. Mater. 18, 1365\u20131370 (2006).","journal-title":"Adv. Mater."},{"key":"46130_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","volume":"203","author":"AA D\u2019Souza","year":"2015","unstructured":"D\u2019Souza, A. A. & Devarajan, P. V. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications. J. Control. Release 203, 126\u2013139 (2015).","journal-title":"J. Control. Release"},{"key":"46130_CR46","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0076-6879(10)79013-3","volume":"479","author":"PK Grewal","year":"2010","unstructured":"Grewal, P. K. The Ashwell\u2013Morell receptor. Methods Enzymol. 479, 223\u2013241 (2010).","journal-title":"Methods Enzymol."},{"key":"46130_CR47","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.1021\/bi00495a001","volume":"29","author":"M Spiess","year":"1990","unstructured":"Spiess, M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry 29, 10009\u201310018 (1990).","journal-title":"Biochemistry"},{"key":"46130_CR48","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.1021\/jacs.2c12824","volume":"145","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Targeted biomolecule regulation platform: a split-and-mix PROTAC approach. J. Am. Chem. Soc. 145, 7879\u20137887 (2023).","journal-title":"J. Am. Chem. Soc."},{"key":"46130_CR49","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638\u2013654 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"46130_CR50","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1016\/j.molcel.2021.09.021","volume":"81","author":"X Ling","year":"2021","unstructured":"Ling, X. et al. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates. Mol. Cell 81, 4747\u20134756 (2021).","journal-title":"Mol. Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46130-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46130-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46130-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T16:04:24Z","timestamp":1708704264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46130-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["46130"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-46130-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1663"}}